| Annual Financials | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
Revenue  | 17 | 12 | 11 | 12 | 16 | 15 | 42 | 8 |
| Expenses | 16 | 11 | 10 | 10 | 15 | 14 | 39 | 7 |
| EBITDA | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 2 |
| Operating Profit % | 5 % | 7 % | 7 % | 21 % | 5 % | 5 % | 8 % | 8 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 2 | 0 | 0 | 3 | 1 |
| Tax | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 |
| Net Profit | 0 | 0 | 0 | 1 | 0 | 0 | 2 | 1 |
| EPS in ₹ | 0.20 | 0.15 | 0.10 | 1.25 | 0.12 | 0.16 | 1.37 | 2.20 |
Vilin Bio Med
Vilin Bio Med
46.00
-1.85
(-3.87%)
Market Cap
70.15 Cr
PE Ratio
37.98
Volume
20,000.00
Day High - Low
46.45 - 46.00
52W High-Low
54.40 - 18.95
Key Fundamentals
Market Cap
70.15 Cr
EPS
1.37
PE Ratio
37.98
PB Ratio
2.57
Book Value
18.60
EBITDA
3.19
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
0.97
Debt to Equity
0.20
Actual
Company News
View All News
Vilin Bio Med FY26 net profit rises 763%
4 days ago
4 days agoVilin Bio Med reported a 763% surge in net profit to ₹192.88 lakh for FY26, driven by robust revenue growth. Revenue from operations jumped 185% to ₹4,226.30 lakh.
Vilin Bio Med disclosed that promoters and PACs held no encumbrances on shares in FY26. Total promoter holding stands at 90,04,374 shares.
Vilin Bio Med CFO resigns effective June 11Jun 12, 2026
Jun 12, 2026Vilin Bio Med accepted Avula Hariprasad's resignation as CFO due to pre-occupation. The change is effective June 11, 2026.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,868.00 | #1 4,48,195.77 | 38.85 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 65.65 | |
6,747.00 | 1,79,111.65 | 70.14 | 10,560.00 | 8.73 | 2,520 | 13.44 | 54.67 | |
4,514.10 | 1,52,777.66 | 70.56 | 13,886.20 | 20.34 | 2,138 | -26.91 | 56.91 | |
1,433.10 | 1,15,763.05 | 29.61 | 29,044.60 | 2.24 | 3,870 | -55.32 | 64.19 | |
1,112.20 | 1,11,913.34 | 21.30 | 26,719.70 | 13.65 | 5,242 | 7.82 | 66.01 | |
1,301.30 | 1,08,612.10 | 25.92 | 33,593.30 | -0.44 | 3,998 | -86.05 | 56.75 | |
2,357.80 | 1,07,761.65 | #1 19.97 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 62.58 | |
2,528.60 | 1,04,381.89 | 54.06 | 14,277.60 | 12.03 | 1,750 | 31.75 | 66.83 | |
1,534.20 | 89,106.59 | 24.74 | 33,384.70 | 3.21 | 3,376 | 1.99 | 64.69 | |
1,481.00 | 79,952.76 | 87.15 | 6,867.80 | #1 22.01 | 890 | 21.18 | 72.60 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
176.21 %
Net Income Growth
880.00 %
Cash Flow Change
102.96 %
ROE
36.62 %
ROCE
13.73 %
EBITDA Margin (Avg.)
-8.15 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 14 | 14 | 14 | 18 | 32 | 28 | 35 |
| Fixed Assets | 2 | 2 | 2 | 2 | 1 | 1 | 3 |
| Current Assets | 12 | 12 | 12 | 8 | 19 | 13 | 27 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 2 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 7 |
| Other Assets | 12 | 12 | 12 | 16 | 31 | 25 | 0 |
| Total Equity & Liabilities | 14 | 14 | 14 | 18 | 32 | 28 | 35 |
| Current Liabilities | 7 | 6 | 5 | 7 | 9 | 5 | 6 |
| Non Current Liabilities | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
| Total Equity | 7 | 7 | 7 | 11 | 23 | 23 | 28 |
| Reserve & Surplus | 4 | 4 | 4 | 1 | 9 | 9 | 13 |
| Share Capital | 3 | 3 | 3 | 10 | 14 | 14 | 15 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 2 | -6 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | -1 |
| Operating Activities | -2 | -1 | 0 | -2 | -7 | 0 |
| Financing Activities | 2 | 1 | -0 | 2 | 9 | -5 |
Share Holding
| % Holding | Jun 2023 | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | May 2026 |
| Promoter | 90.45 % | 64.52 % | 64.52 % | 64.09 % | 63.89 % | 63.89 % | 63.89 % | 63.65 % | 59.57 % | 56.65 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 9.45 % | 32.80 % | 33.84 % | 34.47 % | 34.18 % | 33.49 % | 33.55 % | 33.95 % | 30.19 % | 33.06 % |
| Others | 0.10 % | 2.68 % | 1.65 % | 1.45 % | 1.94 % | 2.62 % | 2.57 % | 2.39 % | 10.24 % | 10.30 % |
| No of Share Holders | 827 | 659 | 585 | 581 | 551 | 492 | 476 | 462 | 421 | 400 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 21 Sept 2024 |  Annual General Meeting | NA | 21 Sept 2024 | 18.85 | 18.05 |
| 30 Oct 2024 |  Quarterly Result Announcement | NA | 30 Oct 2024 | 24.40 | 22.90 |
| 17 May 2025 | Quarterly Result Announcement | NA | 17 May 2025 | 25.35 | 26.55 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 26.50 | 24.95 |
| 09 Feb 2026 |  Extraordinary General Meeting | NA | 09 Feb 2026 | 26.50 | 36.00 |
| 30 May 2026 | Quarterly Result Announcement | NA | 30 May 2026 | 48.50 | 46.55 |
Technical Indicators
RSI(14)
Neutral 60.94
ATR(14)
Volatile 1.12
STOCH(9,6)
Neutral 25.40
STOCH RSI(14)
Neutral 38.21
MACD(12,26)
Bearish -0.52
ADX(14)
Strong Trend 35.31
UO(9)
Bearish 50.19
ROC(12)
Uptrend And Accelerating 2.24
WillR(14)
Overbought -19.54
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
